GE healthcare BIO-sciences:1107247 [18-001823]
Ended Awarded
- Contract number
- HHSN26100022
- Awardee
-
Global Life Sciences Solutions USA LLC UEI FG41DG32EGC3 Part of General Electric Company
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,600
Award facts
- Contract value 100% obligated
- $12,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Global Life Sciences Solutions USA LLC, a wholly owned subsidiary of Danaher Corporation, received a $12,600 Firm Fixed Price contract award from the National Cancer Institute (NCI) on November 13, 2017. This award represents a Blanket Purchase Agreement (BPA) call under the National Institutes of Health's Office of Logistics and Acquisition Operations' $10 million BPA (with completion through November 30, 2025), which enables NIH agencies to procure biological materials, media, chemicals, laboratory supplies, and medical/scientific equipment. The work will be performed in Bethesda, Maryland, with an ultimate completion date of November 16, 2018. No small business set-aside was utilized for this procurement, allowing full and open competition among qualified vendors.
This task order exemplifies the National Cancer Institute's reliance on specialized life sciences vendors to support its biomedical research infrastructure and laboratory operations. Global Life Sciences Solutions USA LLC has established itself as a critical supplier across multiple NIH institutes through its comprehensive offerings of advanced laboratory instrumentation, including chromatography systems, cell processing equipment, and biological materials essential for cancer research and other biomedical initiatives. The company's role as a Danaher subsidiary provides access to sophisticated scientific technologies that support the NCI's mission to reduce cancer incidence and mortality through coordinated research efforts.
Quick answers
Who was awarded contract HHSN26100022?
HHSN26100022 was awarded to Global Life Sciences Solutions USA LLC by National Cancer Institute (National Institutes of Health) on November 13, 2017.
How much is contract HHSN26100022 worth?
The government has obligated $12,600 on HHSN26100022.
Is contract HHSN26100022 an order under another contract?
Yes. HHSN26100022 is a BPA call under HHSN263201600055B, a blanket purchase agreement.
Was contract HHSN26100022 competed?
The extent of competition for HHSN26100022 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award